Riskpilot← Back to searchSign inGet full accessMeelunie GPI A/S
A/SActiveCVR 42057177Karosserivej 14Engineering activities and related technical consultancy · NACE 7112Est. 202136 employeesmeeluniegpi.com
Revenue 2025
DKK -27,9M
+102% vs 2024
EBITDA margin
167.8%
-115% vs 2024
Equity ratio
-9.1%
Financial strength
Net profit 2025
DKK -99,3M
-87% vs 2024
| Revenue | DKK -27,9M | +102% |
| EBITDA | DKK -46,7M | -115% |
| Net profit | DKK -99,3M | -87% |
| Total assets | DKK 582,2M | +10% |
| Equity | DKK -52,8M | -214% |
| Employees | 36 | — |
Legal name
Meelunie GPI A/S
CVR number
42057177
Legal form
Aktieselskab
NACE code
7112 · Engineering activities and related technical consultancy
Founded
21. januar 2021
Share capital
DKK 1.002.000
Employees
36 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af alle bestyrelsesmedlemmer i forening eller selskabets administrerende direktør i forening med et medlem af bestyrelsen.
Company purpose
Selskabets formål er at producere og sælge protein og stivelsesprodukter og andre aktiviteter tilknyttet hertil. Selskabet tilstræber at drive sin virksomhed under hensyntagen til samfundet og miljøet som helhed.
Address
Karosserivej 14
Email
info@meeluniegpi.com
Website
meeluniegpi.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | -991 | -2.853 | -3.538 | -13.810 | -27.851 |
| Staff expenses | -741 | -3.133 | -3.333 | -7.909 | -18.896 |
| EBITDA | -1.731 | -5.985 | -6.871 | -21.719 | -46.746 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -11.924 |
| EBIT | -1.731 | -5.985 | -6.871 | -21.719 | -58.670 |
| Net financials | -262 | -1.106 | -13.307 | -31.261 | -40.635 |
| Profit before tax | -1.993 | -7.091 | -20.179 | -52.980 | -99.306 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | -1.993 | -7.091 | -20.179 | -52.980 | -99.306 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 103.372 | 219.066 | 358.574 | 526.963 | 582.180 |
| Equity | 101.007 | 119.666 | 99.487 | 46.507 | -52.799 |
| Long-term debt | 0 | 55.500 | 153.850 | 314.032 | 562.957 |
| Short-term debt | 2.365 | 43.900 | 105.237 | 166.424 | 72.022 |
| Total debt | 2.365 | 99.400 | 259.087 | 480.456 | 634.979 |
EBITDA margin
-4674625400.0%
This company
15.8%
Market median
-29586236809% vs market
20212025
Equity ratio
-9.1%
This company
38.2%
Market median
-124% vs market
20212025
Return on equity
-9930554000.0%
This company
18.4%
Market median
-53970402274% vs market
20212025
Net profit margin
-9930554000.0%
This company
8.1%
Market median
-122599432199% vs market
20212025
Asset turnover
-0.05×
This company
1.12×
Market median
-104% vs market
20212025
Debt / equity
12.03×
This company
0.62×
Market median
-1840% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2021-01-21 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LD Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Chairman | 2023 | |
| Former (4) | ||
| Board of Directors | 2021 – 2023 | |
| Board of Directors | 2023 – 2023 | |
| Chairman | 2021 – 2023 | |
| Board of Directors | 2021 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50–66.65% | 50–66.65% | 2021 | |
| Company | 50–66.65% | 50–66.65% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
OK BIOTECH ApS
Meelunie GPI A/S Board members of Meelunie GPI A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Dahl Laursen | Chief Executive Officer | 0 companies |
| Roland Henrikus Wilhelm | Board of Directors | 0 companies |
| Gijs van Elst | Board of Directors | 0 companies |
| Marcel Kappe | Board of Directors | 0 companies |
| Jes Gravgaard Jensen | Board of Directors | 0 companies |
| Ole Ejner Viggo Andersen | Chairman | 0 companies |
| Ole Kaae Hansen | Board of Directors | 0 companies |
| Frank Sluis | Board of Directors | 0 companies |
| Marco Heering | Board of Directors | 0 companies |
| Nicolai Winding Andersen | Board of Directors | 0 companies |
| Sander Christian Hulsebos | Chairman | 0 companies |